Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Jurriaan B. Tuynman

ResearcherPublications, citations & collaboration network

Jurriaan B. Tuynman is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 343 works, 15,118 citations, an h-index of 58 and an i10-index of 155.

343
Works
15,118
Citations
58
h-index
155
i10-index

How has Jurriaan B. Tuynman's publication output changed over time?

ScholarIQpublication output · 2010–2021

Output grew0% over the shown period — from 1 works in 2010 to 1 in 2021.

1
1
2
1
1
3
1
1
20102011201320152016201920202021

What are the most-cited papers on Jurriaan B. Tuynman?

ScholarIQmost cited works
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Louis Vermeulen, Felipe de Sousa e Melo, Maartje van der Heijden, Kate Cameron, Joan H. de Jong, Tijana Borovski, Jurriaan B. Tuynman, Matilde Todaro, Christian J. Merz, Hans M. Rodermond, Martin R. Sprick, Kristel Kemper, Dick J. Richel, Giorgio Stassi, Jan Paul Medema
S151741590. 20101,794 Citations
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, Corrie A.M. Marijnen, Hein Putter, Elma Meershoek‐Klein Kranenbarg, Annet G.H. Roodvoets, Irıs D. Nagtegaal, Regina G. H. Beets‐Tan, Lennart K. Blomqvist, Tone Fokstuen, Albert J. ten Tije, Jaume Capdevila, Mathijs P. Hendriks, Ibrahim Edhemović, Andrés Cervantes, Per J. Nilsson, Bengt Glimelius, Cornelis J.�H. van de Velde, Geke A.P. Hospers, Lars Østergaard, Frank Svendsen Jensen, Per Pfeiffer, K.E.J. Jensen, Mathijs P. Hendriks, Wilhelmina H. Schreurs, H.P. Knol, J.J. van der Vliet, Jurriaan B. Tuynman, A. Bruynzeel, Emile D. Kerver, Sebastiaan Festen, Monique E. van Leerdam, Geerard L. Beets, L. Dewit, C.J.A. Punt, Pieter J. Tanis, Elisabeth D. Geijsen, Peter Nieboer, Wim Bleeker, Albert J. ten Tije, Rogier M. P. H. Crolla, Addy C.M. van de Luijtgaarden, Jan Willem T. Dekker, J.M. Immink, Frank J. Jeurissen, Andreas Marinelli, Heleen M. Ceha, Tanja C. Stam, P. Quarles an Ufford, Willem H. Steup, Alex L.T. Imholz, R.J.I. Bosker, Jasper Bekker, G.J. Creemers, Grard A. P. Nieuwenhuijzen, Henk van den Berg, Wendy M. van der Deure, Roderick F. Schmitz, Johan M. van Rooijen, Annette F. T. Olieman, A.C.M. van den Bergh, Derk Jan A. de Groot, Klaas Havenga, Jannet C. Beukema, Jacob D. de Boer, Peter H.J.M. Veldman, Ester Siemerink, J.W.P. Vanstiphout, B. De Valk, Q. A. J. Eijsbouts, M. Polée, Christiaan Hoff, Annerie Slot, H.W. Kapiteijn, Koen Peeters, Femke P. Peters, P.A. Nijenhuis, Sandra A. Radema, Hans De Wilt, Pètra M. Braam, G.J. Veldhuis, Daniël A. Hess, Tom Rozema, O. Reerink, Daan ten Bokkel Huinink, A. Pronk, Josephine M. I. Vos, Metin Tascilar, Gijs A. Patijn, Christian Kersten, Odd Mjåland, Marianne G. Guren, Arild Nesbakken, Janez Benedik, Ibrahim Edhemović, Vaneja Velenik, Jaume Capdevila, Eloy Espín, Ramón Salazar
The Lancet Oncology. 20201,669 CitationsOPEN ACCESS
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
Felipe de Sousa e Melo, Xin Wang, Marnix Jansen, Evelyn Fessler, Anne Trinh, Laura de Rooij, Joan H. de Jong, Onno J. de Boer, Ronald van Leersum, Maarten F. Bijlsma, Hans M. Rodermond, Maartje van der Heijden, Carel J.M. van Noesel, Jurriaan B. Tuynman, Evelien Dekker, Florian Markowetz, Jan Paul Medema, Louis Vermeulen
Nature Medicine. 2013778 Citations
COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer
Charlotte L. Deijen, Simone Velthuis, Alice Tsai, Stella Mavroveli, Elly S.M. de Lange–de Klerk, Colin Sietses, Jurriaan B. Tuynman, Antonio M. Lacy, George B. Hanna, H. Jaap Bonjer
Surgical Endoscopy. 2015383 CitationsOPEN ACCESS
Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
Felipe de Sousa e Melo, Selçuk Çolak, Joyce Y. Buikhuisen, Jan Köster, Kate Cameron, Joan H. de Jong, Jurriaan B. Tuynman, Pramudita R. Prasetyanti, Evelyn Fessler, S. Bergh, Hans M. Rodermond, Evelien Dekker, Chris M. van der Loos, Steven T. Pals, Marc J. van de Vijver, Rogier Versteeg, Dick J. Richel, Louis Vermeulen, Jan Paul Medema
S128124174. 2011337 CitationsOPEN ACCESS

Related on ScholarIQ

Amsterdam Neuroscience
Institution
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Paper
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Paper
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
Paper
COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer
Paper
Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
Paper
470M+ articles · free account